Spondylitis Trial of Apremilast for Better Rheumatic Therapy
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of apremilast in AS as measured by improvement in
patients' signs and symptoms of the disease and changes in imaging. Additionally the safety
and tolerability of apremilast in AS will be assessed.